Gabapentin is a prescription medication approved by the FDA for the treatment of neuropathic pain (postherpetic neuralgia) and seizure disorders. Why is gabapentin controlled in some states? Gabapentin is structurally and pharmacologically related to pregabalin (Lyrica, Lyrica CR), which is a Schedule V drug and controlled federally in all states. Learn about Oregon’s prescribing guidelines for controlled substances, including regulatory requirements, compliance expectations, and enforcement policies. (a) Immediate administration of the controlled substance is necessary, for proper treatment of the intended ultimate user; and (b) No appropriate alternative treatment is available, including administration of a drug which is not a controlled substance under schedule II of the Act, and Chemistry: Gabapentin is chemically known as 2-[1-(aminomethyl) cyclohexaneacetic acid]. Gabapentin closely resembles pregabalin, a schedule V drug under the Controlled Substances Act in its chemical structure and pharmacological activity. The Drug Enforcement Administration announced the proposed rules on Friday, which state that telehealth flexibilities will be extended for common, non-controlled medications but schedule II. Should gabapentin be a controlled substance? (how to identify a Oregon.gov website) It contains information provided by Oregon-licensed retail pharmacies. . Avoid alcohol use during gabapentin treatment. Avoid other central nervous system depressants, including drugs that make you sleepy or dizzy. Future of gabapentin regulation As of June 2024, gabapentin remains a non-controlled substance under the U.S. federal government. If gabapentin is, or becomes, a controlled substance in your state, it does not necessarily mean it will be more difficult to obtain. Rather, it is a safety measure to assure we are using medications appropriately. Individuals at the highest risk for abusing gabapentin include those with opioid abuse, mental illness, or previous history of prescription drug abuse. States are now taking action to track gabapentin use through prescription monitoring programs, and some states have reclassified it as a Schedule V controlled substance. Prescribers and pharmacists are only allowed to search information regarding patients under your care. The PDMP collects data on Federally Scheduled II, III, and IV controlled substances, State Scheduled drugs including pseudoephedrine, state drugs of interest gabapentin and naloxone. The Oregon PDMP maintains this data for 3 years from pharmacy fill date. Medical, dental, and pharmacy Oregon Administrative Rules Chapter 855, Board of Pharmacy; Division 80, Schedule of Controlled Substances. Refreshed: 2025-05-10 Learn whether gabapentin is a controlled substance, as well as risks of prescription drug abuse and treatment for gabapentin addiction. Gabapentin is a controlled substance in states like Michigan and Kentucky, while others have mandated reporting rules. Learn about its risk for abuse here. Due to concerns about the potential misuse of gabapentin, some states have classified the drug as a controlled substance. Other states have put stricter measures in place to monitor possible misuse of gabapentin. Overall, the total number of prescriptions for controlled substances slightly increased (2.6%) compared to the 2nd quarter of 2022. Gabapentin was the most prescribed substance in the system with a slight increase (1.9%) in prescriptions over Q2 2022. Stimulant prescriptions increased with amphetamine prescriptions up 3.2% and methylphenidate prescriptions increasing 17.0% (Table 5 Gabapentin, originally developed to treat epilepsy, has gained popularity as a medication for neuropathic pain and other conditions. However, its increasing use has raised concerns about potential misuse and addiction. As a result, various states have begun to classify gabapentin as a controlled substance. Understanding the legal status of gabapentin across different jurisdictions is crucial The Oregon PDMP collects data on Schedules II, III and IV controlled substances and gabapentin. Beginning Jan 2025, the PDMP will begin collecting schedule V drugs and veterinarian prescribed controlled substances. Pharmacies submit prescription data to the PDMP system for all Schedules II, III and IV controlled substances, gabapentin, and naloxone dispensed from Oregon pharmacies and to Oregon residents from non-resident pharmacies. The protected health information is collected and stored securely. For Controlled Substance drug loss reporting, the board expects an initial email notification as well as a follow-up/final notification, once the situation is resolved. Resolved means that an internal investigation has been completed and all pertinent details of the drug loss have been identified. We would like to show you a description here but the site won’t allow us. (1) In the administration, distribution, storage, prescribing, and dispensing of controlled substances, APRNs shall comply with all applicable requirements in the Code of Federal Regulations (CFR), Title 21, and state law, including but not limited to, ORS Chapter 430 (Mental Health) and 475 and OAR chapter 415 and 855. (2) Nurse practitioners and clinical nurse specialists shall not dispense
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |